Chetan Kulkarni

Chetan Kulkarni is an experienced executive in the pharmaceutical and biotechnology industries, currently serving as Executive Director at Chryselys since February 2024. Prior to this role, Chetan held the position of Director, US Commercial Insights & Analytics at Kite Pharma from April 2022 to February 2024, where responsibilities included analyzing market dynamics and developing sales and marketing strategies. Chetan also served as Director of Insights & Analytics at Sandoz from October 2020 to April 2022, focusing on the biosimilars market, and held the position of Associate Director of Analytics & Data Science at Novartis from June 2014 to October 2020. Early career experience includes strategic planning at Dr. Reddy's Laboratories from May 2010 to June 2014. Chetan holds a Bachelor's degree in Information Technology from the National Institute of Technology Karnataka and an MBA from Symbiosis Centre For Management and Human Resource Development.